MPR Weekly Dose Podcast Episode 12

from MPR Weekly Dose · host MPR Weekly Dose

This week we talk about NDMA findings in ranitidine products; Approval of a new flu vaccine; The return of an antiarrhythmic agent; A new treatment for H. pylori infection; and the risk of biotin interference in test results which could lead to missed diagnoses.

Episode metadata supplied by the publisher feed · Published Nov 8, 2019

Embed this episode

Attribution link and audio player

Ready to play

MPR Weekly Dose Podcast Episode 12

0:00 5:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of MPR Weekly Dose?

This episode is 5 minutes long.

When was this MPR Weekly Dose episode published?

This episode was published on November 8, 2019.

Can I download this MPR Weekly Dose episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!